Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Neoadjuvant Therapy

Known as: Neoadjuvant Treatments, Treatments, Neoadjuvant, Induction Therapy 
Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy… Expand
National Institutes of Health

Related topics

Related topics

2 relations
nursing therapystandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
BACKGROUND Pathological complete response has been proposed as a surrogate endpoint for prediction of long-term clinical benefit… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2012
Highly Cited
2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised…
BACKGROUND Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2012
Highly Cited
2012
Preoperative chemoradiotherapy for esophageal or junctional cancer.
BACKGROUND The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction… Expand
  • figure 1
  • table 1
  • table 2
  • table 2
  • figure 2
Review
2010
Review
2010
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Jörg Kleef and colleagues systematically reviewed studies on neoadjuvant therapy and tumor response, toxicity, resection, and… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2008
Highly Cited
2008
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and… Expand
Highly Cited
2003
Highly Cited
2003
Repeated observation of breast tumor subtypes in independent gene expression data sets
Characteristic patterns of gene expression measured by DNA microarrays have been used to classify tumors into clinically relevant… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2003
Highly Cited
2003
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
BACKGROUND Despite aggressive local therapy, patients with locally advanced bladder cancer are at significant risk for metastases… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Highly Cited
2003
Highly Cited
2003
Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.
PURPOSE To investigate the effect of pelvic lymph node dissection and radical cystectomy for transitional cell cancer of the… Expand
Highly Cited
2000
Highly Cited
2000
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
BACKGROUND Despite more than 70 randomised trials, the effect of chemotherapy on non-metastatic head and neck squamous-cell… Expand
Highly Cited
1998
Highly Cited
1998
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
PURPOSE To determine, in women with primary operable breast cancer, if preoperative doxorubicin (Adriamycin) and cyclophosphamide… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE